New ADHD Subtype Identified in Brain Scan Study
Researchers identified a severe form of the condition that may help guide future personalized care for children.
Updated on Oct. 23, 2026 in Autism
Live Poll
Should medical diagnostic standards prioritize neuroimaging evidence over patient-reported symptoms?
Researchers have identified three distinct ADHD subtypes, including a severe-combined version marked by emotional dysregulation. This new framework could eventually inform personalized treatment strategies for children and adolescents living with the condition.
Why it matters
Identifying specific biological subtypes may lead to more precise care, as current diagnostic criteria do not account for the emotional dysregulation often seen in severe ADHD cases. This classification could influence future updates to standard clinical manuals used for diagnosis.
In a study published in JAMA Psychiatry, researchers analyzed 1,154 brain scans of children and adolescents to map neurobiological differences. The results identified three ADHD subtypes, noting 45 distinct brain abnormalities in the severe-combined group versus 26 in the other two.
The players
New York University
A major research institution that contributed to the neuroimaging analysis.
SUNY Upstate Medical University
A public health and academic center home to the research commentator.
The details
Researchers utilized neuroimaging and computational modeling to compare how different pathways of the brain function across ADHD presentations. The severe-combined subtype is defined by unique structural abnormalities in regions responsible for emotional regulation and impulse control. By mapping these specific brain pathways, the study distinguishes how neurobiological differences correlate with outward behavioral patterns.
Timeline
2022 marked the most recent update to the DSM-5.
The study findings were published in October 2026.
Health Landscape
This study challenges the existing diagnostic framework established by the DSM-5 clinical criteria. It signals a move toward a neurobiology-based classification system for ADHD that could redefine how clinicians assess and treat behavioral symptoms.
These findings are preliminary and are not currently used in a clinical setting to change a diagnosis or treatment plan. If your child or adolescent experiences significant emotional dysregulation, it is worth discussing these behavioral patterns with a physician to explore current care options.
The takeaway
While currently a research development, this work highlights that ADHD is a complex, biologically diverse condition. Families should focus on tracking specific behavioral patterns and emotional health to discuss with their healthcare provider during routine checkups.
Further reading
For more on evolving diagnostic research, visit Autism.
Source note: This article includes information reported by ADDitude.
Live Poll
Should medical diagnostic standards prioritize neuroimaging evidence over patient-reported symptoms?
